Search

CT Lung Analysis & Lung CAD

CT Lung Analysis* aids in measuring and characterizing lung nodules. The interface and automated tools help to efficiently determine growth patterns and compose comparative reviews.

Key Benefits

  • Automated segmentation of lung and airways with expert presets for visualization
  • Single-click lung nodule segmentation tools to include solid nodules and ground glass opacity (GGO) nodules
  • Quantification of lung nodules with nodule growth and doubling times in comparison studies
  • Streamlined workflow transfers lung nodule findings to your site’s existing PowerScribe® 360 deployment
  • Additional software offerings (CT Lung Density Analysis, Lung CAD, Visia CT Lung CAD) for Lung Screening Initiatives

Lung CAD

  • Lung CAD is a computer-aided detection (CAD) system for chest multi-slice CT exams. Lung CAD automatically detects potentially actionable lung nodules from 4 mm to 30 mm in size. Lung nodules detected in Lung CAD can be shown within CT Lung Analysis.

Key Benefits

  • Improves technologist’s and radiologist’s workflow by automatically detecting pulmonary nodules in CT images
  • Clinically validated CAD performance designed to help improve reader accuracy
Image

Photorealistic view with Global Illumination

Global Illumination is a new revolutionary 3D/4D rendering technique to help provide a more photorealistic view of human anatomy, available within existing Vitrea Advanced Visualization workflows. Global Illumination Rendering (GIR) provides easy to understand images that are excellent for explaining examination results to patients

Learn more about Global Illumination
  • Vitrea Advanced Visualization is owned and manufactured by Canon Medical Informatics, Inc.
    Lung CAD is a separately licensed feature within the CT Lung Analysis application
    Lung CAD is not available in the U.S.
Image

Your partner to fight against lung cancer

Lung cancer is one of the most frequent causes of cancer and the leading cause of cancer death globally1. However, when the disease is detected at an early stage, the chances of survival increase dramatically2.

Canon offers a unique set of lung cancer screening solutions. These include a suite of innovative technologies to enhance your clinical confidence everywhere, delivering high-quality imaging at low dose, streamlining workflows, and offering comprehensive diagnosis throughout the entire cycle of care.

1. Globocan 2020
2. Oudkerk M. et al | Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives | Nature Reviews Clinical Oncology (2021)

Learn more about Canon lung cancer screening solutions